openPR Logo
Press release

Gene Editing Market - Analysis Market with Current Trends Analysis upto 2025

11-07-2017 06:04 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: TMR Research

Gene Editing Market - Analysis Market with Current Trends Analysis upto 2025

Global Gene Editing Market: Snapshot

Gene editing or genome editing is the targeted insertion or modification of cells in living organism or cells and the method has come to occupy a crucial part of biomedical researches, constantly transforming various disciplines of life sciences. Over the past few years, continuous advancements in gene-editing technologies have led to the advent of several versatile methods, which have enabled investigators to introduce a number of sequence-specific changes into the genomes of a variety of cell types. This has facilitated the discovery of promising human gene therapies proving useful for treating various diseases. The use of targeted nucleases or engineered nucleases in laboratories has provided researchers potential tools to economically and rapidly manipulate almost any genomic sequence for a broad range of cell types.

In recent years, gene editing techniques have been witnessed a paradigmatic shift with the advent of methods such as clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9), zinc-finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALENs). Using these technologies, investigators have been successful in generating a wide spectrum of outcomes, which are likely to prove useful in diverse areas as synthetic biology, disease modeling, neurosciences, and drug discovery. For instance, targeted nuclease have enabled the insertion of targeted DNA double-strand breaks (DSBs). This has led to the activation of DNA repair pathways in various cells. In vivo applications of various gene editing tools, however, suffer from noticeable constraints. For instance, nuclease delivery or expression can be enabled only in diseased cells, thereby limiting potential of the market to an extent. Nevertheless, constant engineering advances are being made which will expectedly lay robust groundwork for expanding the current array of genome-modifying tools.

Request Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=638

Global Gene Editing Market: Overview

Gene editing involves the insertion, deletion, or replacement of DNA at specific sites in the genome of a cell or an organism. It is usually achieved in a laboratory environment using molecular scissors.

Regulations for the security of life, well-being of plants and animals, human health, and environmental compliance will influence market players for increased focus on import, export, and commercialization of genetically modified organisms (GMOs).

The report is an all-important tool to comprehend the various factors and growth trends that will influence the growth of the gene editing market between 2017 and 2025. The market study is a collective of facts and factoids that are associated with the global gene editing market in a chronological order. The analysis of past data and current market trends enable research analysts to present a satisfactory conclusion regarding the market’s future. Thus, the analysis presented in the report can be used to devise successful business strategies for the future. Using standard analytical tools such as Porter’s Five Forces and SWOT analysis, the report presents the indices of strength, weakness, opportunities, and threats of the global gene editing market until the end of the forecast period in 2025.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=638

Global Gene Editing Market: Drivers and Restraints

The increasing expenditures on research and development, growth of the biotechnology and pharmaceutical companies, and rising demand for synthetic genes are the major factors driving the global gene editing market.

The increasing prevalence of infectious diseases, cancer, and other genetic disorders is steering the growth of the gene editing industry. Moreover, the increasing demand for personalized medicine and advancement of medical science is propelling the industry’s demand.

However, strict government regulations to receive approval for mutation undertakings and lack of public awareness will challenge the growth of the gene editing market. Government regulations for assessing the medical benefits as well as the potential hazards of gene editing procedure will benefit the growth of this market.

Get Discount @ www.tmrresearch.com/sample/sample?flag=D&rep_id=638

Global Gene Editing Market: Market Segmentation

The global gene editing market can be analyzed on the basis of technology, end user, application, and region. In terms of technology, the market can be segmented into CRISPR, ZFN, TALEN and others. On the basis of application, the global gene editing market can be divided into cell line engineering, plant genetic engineering, animal genetic engineering, and others. By end user, the market can be segmented into biotechnology and pharmaceutical companies, contract research organizations, and academic and government institutes.

Global Gene Editing Market: Regional Outlook

The global gene editing market can be divided into the regional segments of North America, Europe, Asia Pacific, and Rest of the World. The U.S. gene editing market is expected to display robust growth due to growth trend manifested by biotechnology and pharmaceutical companies and adoption of advanced technologies such as CRISPR for treating chronic hereditary diseases.

In Europe, the U.K. is expected to contribute significantly to the growth of the gene editing market in this region. This is mainly due to the rising geriatric population and increasing incidence of chronic diseases. The Asia Pacific gene editing market is expected to display fast growth rate in the coming years. The rising geriatric population, modernization of healthcare practices, technological advancements, and government initiatives for controlling diseases are fuelling the growth of the Asia Pacific gene editing market.

South Africa is expected to contribute significantly to the revenue of its regional market. The rising prevalence of sickle cell anemia, HIV, hemophilia and several forms of cancer will drive the industry’s growth.

Major Companies Mentioned in Report

The report mentions and profiles some of the top companies in the global gene editing market, namely Agilent Technologies, AstraZeneca, Cellectis, Editas Medicine, Dharmacon, Qiagen, Sigma-Aldrich, Allele Biotech, Bio Rad, CRISPR Therapeutics, GE Healthcare, Lonza, Recombinetics, and Thermo Fisher Scientific.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gene Editing Market - Analysis Market with Current Trends Analysis upto 2025 here

News-ID: 804139 • Views: 171

More Releases from TMR Research

Pharmacy Benefit Management Services Market Challenges On Upcoming Trends 2025 | …
Global Pharmacy Benefit Management Services Market: Snapshot Serving as a middleman between drug manufacturers, pharmacies, and healthcare insurance companies, vendors operating in the global pharmacy benefit management services market could be advantaged by the rising costs of several drugs. Insurance companies and insurers are expected to heavily rely on pharmacy benefit management services to lower drug costs. Moreover, pharmacy benefit management services are considered as key players in the overall healthcare
Nocturia Market 2017-2025: Astellas Pharma Inc., Allergan, Inc., Urigen Pharmace …
Global Nocturia Market: Snapshot Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria. Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=296 The regional analysis covers: North America Latin America Europe Asia Pacific Middle East
String Inverter Market Segmentation Detailed Study with Forecast to 2025 | KACO …
Global String Inverter Market: Snapshot String inverters are used for converting direct current (DC) into alternating current (AC). Strict government regulations towards the use of fossil fuels coupled with the soaring demand for uninterrupted electricity supply is stoking the growth of the global market for string inverters. In addition to this, the introduction of various schemes by governments to promote the adoption of renewable energy is working in favor of
Global Self-checkout Systems Market : Industry Key Player - ITAB Scanflow, Diebo …
Global Self-checkout Systems Market: Overview Continuing to extend its popularity in global retail and shopping stores, self-checkout systems cancel the need for human assistance or a retail agent by automating the checkout process, which includes making payments and scanning and bagging purchased items. These systems are a massive investment for retailers and thus, they need to be user-friendly and intuitive. While the systems are still far from being perfect, it

All 26023 Releases


More Releases for Gene

Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Gene Synthesis Market Size 2017-2022 OriGene, Gene Oracle, Genescript
e Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded
Gene Therapy Drug Pipeline Analysis
“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight
Cancer Gene Therapy Market Analysis
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant
Global Gene Editing Technologies Market
Gene editing with engineered nucleases is anticipated to contribute significantly to the global life sciences industry. Gene editing provides application from studying gene functions in plants and animals to gene therapy in humans. Gene editing has more efficiency than many other methods in reverse genetics. Increased development of genetic engineering and increased funding in the field of gene editing is anticipated to drive the growth of the global gene editing
Novel Therapy Changes Gene Expression
A recently published pilot study indicates that a new type of therapy may cause changes in gene expression. The study compared the DNA profiles of four participants who received first a placebo intervention and then, a week later, an hour of an evidence-based therapy. It measured DNA samples collected via saliva, which is a novel non-invasive method that does not require a blood draw. It was the first-ever study to